FORT SHERIDAN ADVISORS LLC Sangamo Therapeutics, Inc. Transaction History

FORT SHERIDAN ADVISORS LLC portfolio value:

$363,000
portfolio value

FORT SHERIDAN ADVISORS LLC quarter portfolio value change:

+18.36%
quarter

Sangamo Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -0.44% -327 shares 55K $4.9 74.05K
Q2 2022 share Increase +0.54% 400 shares -122K $4.14 74.37K
Q1 2022 share Decrease -1.23% -920 shares -132K $5.81 73.97K
Q4 2021 share Decrease -2.52% -1.93K shares -130K $7.81 74.89K
Q3 2021 share Decrease -1.09% -843 shares -238K $9.01 76.83K
Q2 2021 share Increase +2.28% 1.73K shares -22K $11.97 77.68K
Q1 2021 share Increase +6.70% 4.77K shares -159K $12.53 75.94K
Q4 2020 share Increase +15.48% 9.54K shares 529K $15.61 71.17K
Q3 2020 share Increase +39.58% 17.47K shares 186K $9.45 61.63K
Q2 2020 share Increase +4.45% 1.88K shares 127K $8.96 44.15K
Q1 2020 share Increase +52.63% 14.57K shares 37K $6.37 42.27K
Q4 2019 share Increase +18.73% 4.37K shares 21K $8.37 27.69K
Q3 2019 share Increase 0.00% 23.32K shares 211K $9.05 23.32K